Cargando…
Dichlorido[2-(3,5-dimethyl-1H-pyrazol-1-yl-κN (2))quinoline-κN]zinc
The Zn(II) atom in the title compound, [ZnCl(2)(C(14)H(13)N(3))], is coordinated by a Cl(2)N(2) donor set defined by quinoline and pyrazole N atoms of the chelating ligand and two Cl atoms. Distortions from the ideal tetrahedral geometry relate to the restricted bite angle of the chelating ligand [...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344321/ https://www.ncbi.nlm.nih.gov/pubmed/22590087 http://dx.doi.org/10.1107/S1600536812014390 |
Sumario: | The Zn(II) atom in the title compound, [ZnCl(2)(C(14)H(13)N(3))], is coordinated by a Cl(2)N(2) donor set defined by quinoline and pyrazole N atoms of the chelating ligand and two Cl atoms. Distortions from the ideal tetrahedral geometry relate to the restricted bite angle of the chelating ligand [N—Zn—N = 78.54 (12)°]. In the crystal, molecules are connected into a three-dimensional structure by C—H⋯Cl interactions, involving both Cl atoms, and π–π interactions that occur between the pyrazole ring and each of the pyridine and benzene rings of the quinoline residue [intercentroid distances = 3.655 (2) and 3.676 (2) Å]. |
---|